Bone Disease among Children with Sickle Cell Disease: A Scoping Review of Incidence and Interventions

References

• Grégoire-Pelchat P, Alos N, Ribault V, Pastore Y, Robitaille N, Mailhot G. Vitamin D intake and status of children with sickle cell disease in Montreal, Canada. J Pediatr Hematol Oncol. 2018;40(8):e531–e536. doi:10.1097/MPH.0000000000001306
   PubMed Web of Science ®Google Scholar
• Piccin A, Fleming P, Eakins E, McGovern E, Smith OP, McMahon C. Sickle cell disease and dental treatment. J Ir Dent Assoc. 2008;54(2):24–28.
   PubMedGoogle Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. doi:10.1016/S0140-6736(10)61029-X
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:1–22. doi:10.1038/nrdp.2018.10
   PubMed Web of Science ®Google Scholar
• Kavanagh PL, Fasipe TA, Wun T. Sickle Cell Disease: a Review. JAMA. 2022;328(1):57–68. doi:10.1001/jama.2022.10233
   PubMed Web of Science ®Google Scholar
• de Oliveira JF, Vicente NG, Santos JPP, Weffort VRS. Vitamin D in children and adolescents with sickle cell disease: an integrative review. Rev Paul Pediatr. 2015;33(3):349–354. doi:10.1016/j.rppede.2015.06.015
   Google Scholar
• Oyebimpe O, Lynne D, Hematologi D, et al. Osteonekrosis pada penyakit sel sabit: pembaruan pada faktor risiko, diagnosis, dan manajemen; 2019:351–358.
   Google Scholar
• Garrido C, Bardón-Cancho EJ, Fajardo-Sánchez V, et al. Evaluation of the effectiveness of prophylactic oral vitamin D (cholecalciferol) in children with sickle cell disease. Bone. 2020;133:115228. doi:10.1016/j.bone.2020.115228
   PubMed Web of Science ®Google Scholar
• Silva Junior GB, Daher ED, Rocha FA. Osteoarticular involvement in sickle cell disease. Rev Bras Hematol Hemoter. 2012;34(2):156–164. doi:10.5581/1516-8484.20120036
   PubMedGoogle Scholar
• Matos MA, Carrasco J, Lisle L, Castelar M. Avascular necrosis of the femoral head in sickle cell disease in pediatric patients suffering from Hip dysfunction. Rev Salud Pública. 2016;18(6):986. doi:10.15446/rsap.v18n6.50069
   Google Scholar
• Williams KM, Lee MT, Licursi M, Brittenham GM, Fennoy I. Response to long-term vitamin D therapy for bone disease in children with sickle cell disease. J Pediatr Hematol Oncol. 2018;40(6):458–461. doi:10.1097/MPH.0000000000001155
   PubMed Web of Science ®Google Scholar
• Grimbly C, Escagedo PD, Jaremko JL, et al. Sickle cell bone disease and response to intravenous bisphosphonates in children. Osteoporos Int. 2022;33(11):2397–2408. doi:10.1007/s00198-022-06455-2
   PubMed Web of Science ®Google Scholar
• Daltro GC, Fortuna V, De Souza ES, et al. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther. 2015;6(1):1–18. doi:10.1186/s13287-015-0105-2
   PubMedGoogle Scholar
• Novais EN, Sankar WN, Wells L, Carry PM, Kim YJ. Preliminary results of multiple epiphyseal drilling and autologous bone marrow implantation for osteonecrosis of the femoral head secondary to sickle cell disease in children. J Pediatr Orthop. 2015;35(8):810–815. doi:10.1097/bpo.0000000000000381
   PubMed Web of Science ®Google Scholar
• Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(69):2–9. doi:10.1017/cbo9780511814563.003
   PubMedGoogle Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32. doi:10.1080/1364557032000119616
   Google Scholar
• Bradbury-Jones C, Aveyard H, Herber OR, Isham L, Taylor J, O’Malley L. Scoping reviews: the PAGER framework for improving the quality of reporting. Int J Soc Res Methodol. 2022;25(4):457–470. doi:10.1080/13645579.2021.1899596
   Web of Science ®Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/M18-0850
   PubMed Web of Science ®Google Scholar
• JBI. The Joanna Briggs institute critical appraisal tools for use in JBI systematic reviews 2017. The Joanna Briggs Institute Critical; 2017. Available from: https://jbi.global/critical-appraisal-tools. Accessed July 3, 2024.
   Google Scholar
• Alabi I, Salihu M, Arojuraye S, et al. Functional outcome of total hip arthroplasty in teenagers with end stage avascular necrosis of the head of femur resulting from sickle cell disease. J Orthop Rheum. 2021;5(1):15–20. doi:10.36959/479/439
   Google Scholar
• Gatin L, De MAR, Mary P, Vialle R, Gatin L. Osteonecrosis of the femoral head: a proposed new treatment in homozygous sickle cell disease osteonecrosis of the femoral head: a proposed new treatment in homozygous sickle cell disease. Hemoglobin. 2016;40(1):1–9. doi:10.3109/03630269.2015.1092159
   PubMed Web of Science ®Google Scholar
• Itzep NP, Jadhav SP, Kanne CK, Sheehan VA. Spontaneous healing of avascular necrosis of the femoral head in sickle cell disease. Am J Hematol. 2019;94(6):E160–E162. doi:10.1002/ajh.25453
   PubMed Web of Science ®Google Scholar
• Bell V, Varzakas T, Psaltopoulou T, Fernandes T. Sickle cell disease update: new treatments and challenging nutritional interventions. Nutrients. 2024;16(2):1–23. doi:10.3390/nu16020258
   Web of Science ®Google Scholar
• Selma J, Song H, Rivera C, et al. Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice. Blood Adv. 2022;6(5):1381–1393. doi:10.1182/bloodadvances.2021004615
   PubMed Web of Science ®Google Scholar
• Sukmawati S, Hermayanti Y, Fadlyana E, Mulyana AM, Nurhakim F, Mediani HS. Supplementation of prenatal Vitamin D to prevent children’s stunting: a literature review. Int J Womens Health. 2023;15:1637–1650. doi:10.2147/IJWH.S431616
   PubMed Web of Science ®Google Scholar
• Garadah TS, Hassan AB, Jaradat AA, et al. Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease. Clin Med Insights Endocrinol Diabetes. 2015;8:35–40. doi:10.4137/CMED.S24501
   PubMedGoogle Scholar
• Lee MT, Licursi M, McMahon DJ. Vitamin D deficiency and acute vaso-occlusive complications in children with sickle cell disease. Pediatr Blood Cancer. 2015;62(4):643–647. doi:10.1002/pbc.25399
   PubMed Web of Science ®Google Scholar
• Ceglie G, Di Mauro M, Tarissi De Jacobis I, et al. Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study. Front Mol Biosci. 2019;6:1–5. doi:10.3389/fmolb.2019.00140
   PubMed Web of Science ®Google Scholar
• Mulumba LL, Wilson L. Sickle cell disease among children in Africa: an integrative literature review and global recommendations. Int J Africa Nurs Sci. 2015;3(2015):56–64. doi:10.1016/j.ijans.2015.08.002
   Google Scholar
• Valenti MT, Mattè A, Federti E, et al. Dietary ω-3 fatty acid supplementation improves murine sickle cell bone disease and reprograms adipogenesis. Antioxidants. 2021;10(5):1–15. doi:10.3390/antiox10050799
   Web of Science ®Google Scholar
• Martí-Carvajal AJ, Solà I, Agreda-Pérez LH. Treatment for avascular necrosis of bone in people with sickle cell disease. Cochrane Database Syst Rev. 2019;2019(12). doi:10.1002/14651858.CD004344.pub7
   Google Scholar